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1. Introduction 
Blindness is a loss of vision resulting in the inability to continue with a normal lifestyle. The 
prevalence of blindness varies from country to country and from region to region within the 
same country. An average estimate of the number of blind people in industrialized countries 
is 1–2 per 2000, compared to 5–10 per 1000 in developing countries. According to World 
Health Organisation estimates, there are between 27 and 35 million blind people in the 
world today. 
Retinal dystrophies and degenerations represent a heterogeneous group of disorders 
affecting the function of the retina. They are characterized by degeneration of 
photoreceptors or adjacent cells such as retinal pigment epithelium or Müller cells. Retinitis 
pigmentosa (RP), hereditary maculopathies, and age-related macular degeneration (AMD) 
are representative of these diseases. RP as well as macular degeneration can be part of 
syndromes with symptoms from other organs or organ systems, for example, Usher 
syndrome with RP and deafness. More than 190 loci for different retinal diseases have been 
localized, and 140 genes have been identified (http://www.sph.uth.tmc.edu/Retnet/). 
In northern Sweden the presence of all hereditary disorders is higher than in the southern 
part of the country. Explanations offered include a low migration rate in the sixteenth to 
nineteenth centuries and a certain number of marriages among relatives, which influenced 
the presence of autosomal recessive disorders. Furthermore, a disposition to a genetic 
abnormality in a geographically restricted area gave rise to a ‘founder’ effect, which 
influenced the presence of autosomal dominant disorders. These factors are taken into 
consideration in studies of all hereditary disorders, including those affecting vision. 
2. Retinitis pigmentosa 
Retinitis pigmentosa is a genetically and clinically heterogeneous group of hereditary 
retinopathies characterized by a degeneration of photoreceptors (rods primary) with a 
progressive loss of peripheral vision. This leads to night blindness, ‘tunnel vision’, and 
eventually, complete blindness. Typical signs of the disease, except for night blindness and 
progressive loss of the peripheral visual field, are typical pigment deposition in the retina, 
attenuation of the retinal blood vessels, and optic disc pallor. The diagnosis is confirmed by 
an abnormal or extinguished electroretinogram (ERG). RP can be nonsyndromic, syndromic, 
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or systemic, when multiple tissues are affected. Nonsyndromic RP can be inherited in 
autosomal dominant (15–25%), autosomal recessive (5–20%), and X-linked (5–15%) manners 
(Daiger & Pagon, 2000). However, an inheritance pattern is still unknown in many cases. So-
called simplex usually represents an isolated case without any family history. Due to 
different degrees of penetrance and expressivity of RP genes, the phenotype can vary 
between families and even within the same family (Shintani et al., 2009). 
The prevalence in the United States and Europe is approximately 1/3500 to 1/4000, and the 
disorder is the most common cause of blindness among young adults. In Denmark the 
lifetime risk of developing RP is 1/2500 (Haim et al., 2002), and in Sweden it is 1/2000 
(Burstedt et al., 1999). Similar frequencies can be expected in other populations, but they 
have not been well documented. Frequency of RP in certain isolated or consanguineous 
populations might be higher due to mutations in particular genes (Daiger & Pagon, 2000). 
Among known loci and genes there are 57 identified for autosomal dominant RP and 
autosomal recessive RP. Many genes associated with RP encode proteins functioning as 
photoreceptor transcription factors; others are involved in phototransduction and the visual 
cycle or photoreceptor structure (Phelan & Bok, 2000; Fig. 1). Despite many retinal diseases 
having been mapped to specific chromosomal regions, the genes and their functions still 
have not been identified in all cases. 
 
 
Fig. 1. Visual cycle proteins cause retinal degenerations. CRBP = cellular retinol binding 
protein, RPE65 = retinal pigment epithelium-specific protein 65kDa, LRAT = lecithin retinol 
acyltransferase, IRBP = interphotoreceptor retinoid-binding protein, RPE = retinal pigment 
epithelium, IPM = interphotoreceptor matrix, ROS = rod outer segment, ABCR = retina-
specific ATP-binding cassette transporter, CRALBP = retinaldehyde-binding protein 1,  
RGR = retinal G protein coupled receptor, 11-cis RDH = retinol dehydrogenase 5 (11-cis/9-cis). 
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In Västerbotten County of northern Sweden 160 RP cases were identified and genetic defects 
were found in 66%, representing 79 patients with autosomal recessive RP of Bothnia type 
and 27 patients with autosomal dominant RP. However, genetic mechanisms of RP are still 
unknown in patients from other counties of northern Sweden. In this chapter we will focus 
on a disease with characteristic phenotype common in northern Sweden form of autosomal 
recessive RP, Bothnia dystrophy. 
2.1 Autosomal recessive RP, Bothnia Dystrophy (BD) 
Examination of medical records for patients with RP in Västerbotten County in northern 
Sweden has shown an accumulation of cases with a unique phenotype of RP called Bothnia 
dystrophy. Bothnia is the region in northern Sweden west of the Gulf of Bothnia, historically 
known as Bothnia Occidentalis (Fig. 2). Affected individuals showed night blindness with 
onset in early childhood, retinitis punctata albescens (RPA) at some stage of the disease, 
macular degeneration, and markedly elevated dark adaptation (DA) thresholds. 
 
Fig. 2. The map shows the location of Västerbotten County in Scandinavia. 
2.1.1 Genetic cause of BD 
Initially, twenty patients from seven families originating from the same geographic area 
were included in the linkage analysis study aimed at identifying a disease-causing gene 
(Burstedt et al., 1999). All affected individuals had a nonsyndromic type of retinal 
degeneration inherited in an autosomal recessive way (Fig. 3). By statistical two-point lod 
(logarithm [base 10] of odds) score analysis, which is used to determine the linkage between 
trait and a chromosome marker, BD was mapped between the markers D15S526 and FES on 
chromosome 15q26.1. The D15S116, located near the RLBP1 gene showed a maximum lod 
score of 7.79. Since lod score greater than 3 is considered evidence for linkage, the RLBP1 
gene was a strong candidate to cause the BD. Mutation analysis showed that all patients 
were homozygous for a cytosine (C) to thymine (T) change in exon 7 of the RLBP1 gene, 
resulting in a substitution of a conservative arginine to tryptophan at position 234 
Västerbotten County
Arctic circle
Gulf of 
Bothnia 
SWEDEN 
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(c.700C>T, p.R234W) in encoded cellular retinaldehyde-binding protein (Burstedt et al., 
1999). No homozygotes for the c.700C>T mutation were found among 33 unaffected control 
subjects who underwent ophthalmologic examinations or 92 anonymous blood donors. 
 
Fig. 3. A pedigree demonstrating autosomal recessive inheritance of BD in one of the 
families used for linkage analysis study. 
2.1.2 Compound heterozygosity in BD 
Sixty-nine BD cases homozygous for the c.700C>T were identified amongst patients with 
retinal dystrophies. In addition, 10 patients with similar to BD phenotype were heterozygous. 
Further screening for known mutations causing autosomal recessive RP revealed a second 
RLBP1 mutation, a thymine (T) to adenine (A) change, resulting in a substitution of a 
methionine to lysine, c.677 T>A, p.M226K (Köhn et al., 2008). R234W and M226K were shown 
to be allelic and the patients were compound heterozygotes, c.[677T>A]+[700C>T] (Fig. 4). 
 
Fig. 4. Pedigrees of compound heterozygotes (A) and segregation analysis of RLBP1 c.700C>T 
(B) and c.677T>A (C) performed by polymerase chain reaction and restriction fragment length 
polymorphism. (Figure published in Invest Ophthal Vis Sci, 2008;49(7):3172–3177). 
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Frequency of c.677 T>A allele in a matched control population was 0.0021. Among RP 
patients from northern Sweden two were homozygotes for p.M226K mutation. Based on 
allele frequency of R234W (3/250) and M226K (1/466), we believe that R234W was the first 
mutation to appear in northern Sweden, resulting in expected disease incidence of 1.5 per 
10,000 in a population of 257,000 inhabitants. 
Notably, one RLBP1 compound heterozygote BD patient tested for 848 mutations in 29 
genes causing autosomal dominant RP was shown to be a carrier of a mutation in carbonic 
anhydrase IV (CAIV), known to be associated with autosomal dominant retinitis 
pigmentosa RP17 (Rebello et al., 2004; Yang et al., 2005). Presence of this sequence variant in 
6 out of 143 blood donors from a control Swedish population (4%) and phenotype 
undistinguishable from the other BD patients casts doubt on the pathogenic role of the 
CAIV (Köhn et al., 2008), though modifier genes switching off the mutant CAIV protein or 
other factors resisting its function in carriers of Swedish origin remain to be investigated. 
2.1.3 RLBP1 mutations in RP 
To date, at least 12 mutations representing single nucleotide changes, in addition to small 
and one gross deletion have been reported (http://www.hgmd.cf.ac.uk). First homozygous 
RLBP1 mutation was found in a consanguineous family of Indian origin and in one of 
consanguineous kindred from Saudi Arabia, both diagnosed with retinitis punctata 
albescens (Maw et al., 1997; Katsanis et al., 2001). Three additional mutations in the RLBP1 
gene were identified in the patients of European ancestry with recessively inherited RPA 
(Morimura et al., 1999), and in patients of Newfoundland origin with a severe rod cone 
dystrophy two splice junction mutations were detected (Eichers et al., 2002). The reported 
cases of retinal degeneration associated with RLBP1 mutations were either homozygous or 
compound heterozygous (Demirci et al., 2004; Eichers et al., 2002; Fishman et al., 2004; 
Morimura et al., 1999; Nakamura et al., 2005). One of the compound heterozygotes, a 
Japanese patient with RPA, carried the c.700C>T mutation on one allele (Nakamura et al., 
2005). Finally, changes involving single nucleotides are not the only type of mutation that 
affects the RLBP1 gene. A large homozygous deletion was described in a RPA patient 
(Humbert et al., 2006). 
2.1.4 Cellular retinaldehyde-binding protein (CRALBP) 
RLBP1 gene mapped to chromosome 15q26 (Rosenfeld & Dryja, 1995) encodes the human 
cellular retinaldehyde-binding protein (CRALBP) expressing in outer epithelium of the iris, 
ciliary body pigment epithelium, cornea, optic nerve, pineal gland, Müller cells of the retina, 
and retinal pigment epithelium (RPE) (Bridges et al., 1987; Bunt-Milan & Saari, 1983; 
Eisenfeldt et al., 1985; Futterman & Saari, 1977; Saari et al., 1997; Sarthy, 1996). In the RPE, 
CRALBP functions as a carrier protein for endogenous retinoids, such as 11-cis-retinol, 
participating in the visual cycle. 11-cis-retinol can either be stored as an ester in the RPE or 
become oxidized to 11-cis-retinal by 11-cis-retinol dehydrogenase for visual pigment 
regeneration, and consecutively recycled back to the outer segment of photoreceptor cells of 
the retina (Saari, 1990). In vitro studies indicate that the presence of CRALBP diminishes the 
esterification and enhances oxidation of 11-cis-retinol (Saari et al., 1994). 
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A missense mutation of a conserved residue arginine at position 150 of CRALBP abolished 
binding to 11-cis-retinaldehyde. The mutation was shown to be associated with an atypical 
form of autosomal recessive RP in a small consanguineous Indian family (Maw et al., 1997). 
We evaluated binding activities for two recombinant mutant proteins causing BD 
(Golovleva et al., 2003). M226K mutation completely abolished binding of the recombinant 
protein with 11-cis retinaldehyde, while the R234W, in contrast, increased binding activity 
of the recombinant CRALBP (Fig. 5). Double mutant M226K + R234W showed less solubility 
than the wild type rCRALBP (Köhn et al., 2008). 
 
Fig. 5. Retinoid binding analysis of CRALBP mutants R234W (A) and M226K (B). UV-visible 
absorption spectra are shown before and after exposure to bleaching illumination following 
retinoid labelling with either 11-cis- or 9-cis-retinal. Spectra from wild-type rCRALBP  
(black line) and mutant R234W (red line) are indistinguishable and reflect stoichiometric 
binding of 11-cis- and 9-cis-retinal. The absorption spectra from mutant M226K show no 
chromophore absorbance at 425 nm or 400 nm, indicating no bound retinoid  
(Figure published in J Biol Chem, 2001;278:14,12397–12402). 
We also analysed RLBP1 promoter by sequencing 4kb in the upstream region in two BD 
compound heterozygotes. Seven single nucleotide polymorphisms (SNP) were identified; 
six had been reported previously and one was unique (cytosine to thymine change at 
position 2614, C2614T). Haplotype was constructed for BD patients. R234W and C2614T 
9-cis-Retinal 11-cis-Retinal 
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B
www.intechopen.com
 Retinitis Pigmentosa in Northern Sweden – From Gene to Treatment 
 
457 
were both associated with BD phenotype. In experiments with reporter gene expression, 
decrease of expression level was shown when using either the entire ‘affected’ promoter 
haplotype or only C2614T (Golovleva, personal communication). 
Thus, M226K mutation resulted in loss of functional CRALBP, which is true even for R234W 
mutant, since gene expression was decreased due to sequence variant in promoter. 
2.2 Phenotype of retinitis pigmentosa of Bothnia type 
All 79 patients originating from Västerbotten County, with a population of 257,000 
inhabitants, present the phenotype caused by loss of CRALBP function. 
2.2.1 Clinical findings and effects of age 
The BD phenotype is characterized by central and peripheral degeneration of the retina with 
a unique expression of retinitis pigmentosa. All BD patients from the north of Sweden being 
homozygous for either the c.700C>T (p.R234W) (n = 67) or for the c.677T>A (p.M226K) (n = 
2), and compound heterozygous [c.677T>A]+[c.700C>T] (p.M226K+p.R234W) (n = 10), have 
a clinical expression of the disease with a progression of retinal degeneration. The 
progressive maculopathy in BD presents an overall decrease of the visual acuity (VA) with 
age, leading to legal blindness in early adulthood (Fig. 6; Burstedt et al., 2001). 
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Fig. 6. Scatterplot of BD patients showing the relation of weighted distance logMAR visual 
acuity (WVA) with age. (●) Single observations of WVA vs. age in homozygotes c.700C>T 
(p.R234W); n = 49, (y = 0.035 × -0.53). (□) Retrospective recordings of WVA vs. age in 
compound heterozygotes [c.677T>A] + [c.700C>T] (p.M226K + p.R234W); n = 10  
(y = 0.04 × −0.7), and homozygotes c.677T>A (p.M226K) (■); n = 2 (y = 0.03 × -0.32). 
Trendlines are drawn. 
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Notably, testing of monocular low-contrast VA using Sloan letter logarithmic translucent 
contrast charts (10% and 2.5%, Precision Vision®) allowed recording of measurable results, 
predominantly in the younger patients (Burstedt et al., 2005). 
The retinal findings in BD patients show distinct maculopathy with central pigment 
deposits in the teens, and areolar maculopathy is observed in the younger adults (Burstedt 
et al., 1999, 2001, 2010). In the peripheral retina the pigmentations are similar to a ‘salt and 
pepper’ pattern and round retinal atrophies develop paracentrally and/or peripherally with 
age. The areolar atrophies are the most common peripheral findings in BD fundus as the 
degeneration progresses, though discrete pigmentations with an appearance similar to bone 
spicules may occasionally be found. No premature cataract of significance is observed in 
BD, and in advanced cases narrowing of the retinal vessels and pale optic disc are not 
typical findings (Fig. 7). 
 
Fig. 7. Fundus photography. (A) 16-year-old girl, discrete central maculopathy and 
peripheral mottling, (WVA, weighted visual acuity, 0.00 logMAR). (B) 25-year-old woman 
with maculopathy and peripheral areolar atrophies (WVA 0.5 logMAR). (C) 41-year-old 
woman with central maculopathy and central RPA changes (WVA 0.3 logMAR).  
(D) 52-year-old woman with maculopathy, pigmentary changes (WVA 1.2 logMAR),  
and advanced retinal degeneration with retinal atrophies. 
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2.2.2 Morphological changes in BD found with ocular computed tomography 
A generalized early decrease of the central foveal thickness (Ø 1 mm) and the inner ring of 
the retina (Ø 3 mm) are shown with optical coherence tomography (Burstedt et al., 2010). In 
the outer ring (Ø 6 mm), the generalized thinning is seen predominately in the inferior 
regions of the OCT measurement and a trend of more preserved areas of the retinal 
thickness of the superior and nasal regions are observed. The total macular volumes in all 
ages of BD patients are low compared with those of controls. Comparisons of macular 
thickness in each region of the BD patients and age-matched controls are presented in Fig. 8. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Fig. 8. Optical coherence tomography (OCT) macular thickness measurements of 9 areas in 
young BD patients (age 9–34 years, n = 8) and controls (in bold), using a Stratus OCT, model 
3000 (Carl Zeiss Meditec AG, Jena, Germany): the central foveal, the foveal (Ø 1mm), the 
inner ring (Ø 3mm), and the outer ring (Ø 6 mm) with Superior area (S), Inferior area (I), 
Temporal area (T), and Nasal areas (N). The controls are presented with standard deviation 
shown on the graph. (Figure was published in Arch Ophthalmol. 2010;128(8); 989–995).  
The cross-sectional morphology visualized by OCT presents a general thinning of cell layers 
and a reduced outer nuclear layer (ONL) in the youngest BD patients (9–34 years). Also, a 
third high-reflectance band, (3rd HRB), found in the younger cases, diminished in younger 
adults with BD, possibly representing the loss of the outer segment length of 
photoreceptors, predominately the cones in the fovea measured with OCT (Burstedt et al., 
2010; Costa et al., 2004; Sandberg et al., 2005). This finding probably indicates an affection of 
the cone photoreceptors, and a possible degeneration of the outer segments of cones early in 
the course of the BD disease. The decreased retinal thickness and degenerative signs in the 
outer retinal layer were detected early in the course of the disease reported in a compound 
heterozygous patient with mutations in the RLBP1 gene (R103W/R234W) (Nakamura et al., 
2005). Similar to BD, prominent photoreceptor loss in the foveal and extrafoveal retina even 
in the youngest patients studied (6–17 years), with relative preservation localized in the 
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superior–temporal and temporal pericentral retina and the ONL, were demonstrated in the 
patients with Leber congenital amaurosis, another retinal degenerative disease caused by 
mutations in RPE65 gene encoding for a protein active in the visual cycle (Jacobson et al., 
2008). How can an early foveal thinning, suggesting early degeneration of cone 
photoreceptors in BD patients possibly be explained? Studies show that not only the rods 
but the cones also incorporate 11-cis retinoids, derived from the rod and cone visual cycles, 
in their visual pigments, and when examining the visual cycle in the RPE-65 and LRAT 
knock-out mice, diseases affecting the visual cycle, a key role for cell survival, was found to 
be 11-cis-retinal bound to cone opsins, important for retinal protein sorting, transport, and 
targeting (Collery et al., 2008; Zhang et al., 2008). 
2.2.3 Morphological findings of retinitis punctata albescens (RPA) 
The subretinal white lesions, retinitis punctata albescens, were initially observed in the teens 
with BD phenotype (Burstedt et al., 1999, 2001, 2010). The RPA spots often dominate in the 
macula area and adjacent to the arcades, varying from single to multiple generalized white 
lesions scattered over the posterior pole of the retina. Notably, these changes fade as the 
progressive retinal degeneration advances (Fig. 9). 
 
 
Fig. 9. Colour fundus photo and OCT. Top: 23-year-old man; below: 30-year-old woman. 
The vertical line of the binocular fundus photo with multiple generalized RPA traversing 
the retina at the temporal area of the macula between the arcades represents the scan lines of 
the corresponding OCT image presenting cross-sectional, visualized RPA (marked with 
arrows). (Figure published in Arch Ophthalmol. 2010;128(8);989–995). 
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RPA or subtle white lesions of the fundus have previously been described in several 
autosomal recessive RP cases with RLBP1 mutations, and also in other progressive 
degenerative diseases, for example, the rhodopsin-related RP (Demirci et al., 2004; Eichers et 
al., 2002; Fishman et al., 2004; Katsanis et al., 2001; Nakamura et al., 2005; Souied et al., 1996). 
The localization of RPA lesions and their appearance may resemble more commonly known 
retinal lesions like drusen in age-related macular degeneration. However, the RPA lesions in 
BD do not present elevation, disruption, or detachment of RPE. Another finding in AMD is 
an accumulation of drusen between the retina and choriocapillaris that is shown to interfere 
with the exchange of nutrients and products close to the drusen, inducing RPE or neural 
retinal damage with overlaying photoreceptor cell layer thinning, predominately the 
photoreceptor outer segment affection (Holz et al., 2004; Pauleikhoff et al., 1990; Schumann 
et al., 2009). Since similar thinning or compression of the ONL overlaying the RPA lesions is 
observed in BD, a possible cause could be an accumulation of products in the RPE, possibly 
due to the higher affinity and impaired 11-cis-retinal release in the visual cycle in the BD 
phenotype shown in previous studies (Golovleva et al., 2003; He et al., 2009; Saari, 1990). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Progression of visual field defects in a BD case. (A) Small central scotoma is noted in 
one eye at the age of 18. (B, C) Deeper and larger central-paracentral scotomas develop in 
young adulthood. (D) In middle age absolute central-paracentral scotomas are present and 
expanded, finally affecting the peripheral border. (Figure published in Arch Ophthalmol. 
2001;119(2):260–267). 
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2.2.4 Psychophysical findings 
Significant foveal depression was found early in BD by testing foveal threshold with 
Humphrey SITA standard 24-2. The mean deviations in all younger cases show significant 
loss, indicating an overall depression and/or loss of the central parts of the visual field in 
BD. Goldmann perimetries are unaffected in the BD cases under the age of 10, and relative 
parafoveal scotoma and/or ring scotoma is found in the teens, with additional large, deep to 
absolute central scotomas in both eyes, accompanied by a decrease in visual acuity in 
adulthood. The visual fields and the development of defects, registered over a time period 
of 23 years, are presented in Fig. 10. 
In the fifth decade, extensive scotomas are present and only peripheral islets of the visual 
fields remain in middle age. 
2.2.5 Angiographic findings 
The fundus fluorescein angiograms in the early arteriovenous phase show a diffuse 
hyperfluorescence in the anatomic macular area, and locally, in the centre of the fovea, also 
presenting an early retinal thinning. As well as outside the arcades, corresponding to the 
atrophic areas in the colour fundus photograph, a general hyperfluorescence of granular 
type appears, indicating a gross atrophy of the pigment epithelium of the entire retina as a 
common clinical finding in this retinal degeneration (Burstedt et al., 2001). 
2.3 Dark adaptometry and electrophysiological findings 
2.3.1 Dark adaptometry and electrophysiological findings during standard dark-
adapted conditions 
Recovery of dark adaptation shows abnormalities of both rod and cone function (Fig. 11).  
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Fig. 11. Results of dark adaptometry in 14 cases aged 8–59 years. The grey area indicates  
the normal range of recovery of cone and rod sensitivity during dark adaptation for 
corresponding ages. (Figure published in Arch Ophthalmol. 2001;119(2):260–267). 
www.intechopen.com
 Retinitis Pigmentosa in Northern Sweden – From Gene to Treatment 
 
463 
In the younger patients the rod function is severely affected or absent and the cone 
adaptation often shows an extremely high, elevated final threshold, with the final dark-
adapted sensitivity about four log units higher than a normal range. In elderly affected cases 
an even more pronounced cone dysfunction is found (Burstedt et al., 2001, 2003). 
Full-field, single flash, and flicker electroretinograms (ERGs), including the oscillatory 
potentials (OPs) are recorded (UTAS-E 2000 LKC Technologies Inc., Gaithersburg, MD) 
using Burian-Allen bipolar electrodes during standard dark-adapted conditions, according 
to the recommendations of ISCEV (International Society for Clinical Electrophysiology of 
Vision). The outcome of the ERGs in all BD cases is subnormal or with non-recordable 
amplitudes of the rod-isolated b-waves with peak times either within the normal range or 
prolonged compared to controls (Burstedt et al., 2001, 2003, 2008). Representative full-field 
ERGs from five individuals from one family are presented in Fig. 12. The mixed rod-cone b-
waves amplitudes are subnormal/non-recordable with comparatively short peak times in 
the younger cases. The amplitudes of the mixed rod-cone a-waves are found to be within the 
normal range in younger patients and subnormal to non-recordable with a prolonged peak 
time in adulthood. The amplitudes of the cone b-waves are better preserved and are within 
the normal range at the very young age, with peak times within the normal range, but 
prolonged in young adulthood and thereafter. Most of the younger patients had normal 
amplitudes and implicit times of the 30-Hz flicker ERGs that are within the normal limits, 
but already in early adulthood subnormal and delayed. The summed amplitudes of the 
individual oscillatory peaks, representing the Ops, show subnormal values at young age, 
decreasing with age and becoming non-recordable in BD cases older than 40 years of age. 
0
200 (uV )(uV )
Female
8 years
Female
23 years
Female
52 years
Female
42 years
Female
8 years
Female
23 years
Female
42 years
Female
52 years
Cone responses
Mixed rod-cone responses
Rod responses
-100
0
100
-100
0
100
0
100
-100
0
100
-100
0
100
-200
0
-100
0
100
-200
0
-100
0
100
Flicker ERG (30Hz)-300
0
-80
0
80
-100
0
100
-80
0
80
-100
0
100
-80
0
80
-
-
1
2
0
0
0
0
0
0
100
0 50 100 150 200 250
-80
0
80
0 50 100 150 200 250
Norm al
ERG
Norm al
ERG
 
Fig. 12. Full-field ERG responses of the nonaffected individual (above) and BD patients, two 
elderly, and two younger women (52, 42, 23, and 8 years of age, respectively) from the same 
family. (Figure published in Arch Ophthalmol. 2001;119(2):260–267). 
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The ERGs recorded under standard conditions show that the rod and mixed rod-cone b-
wave responses are relatively more affected than the mixed a-wave. The cone b-wave and 
the 30 Hz flicker amplitudes are significantly better preserved than the b-wave amplitudes 
of the rod and mixed rod-cone responses as well as the a-wave amplitude of the mixed rod-
cone response, indicating later disturbance of the cones compared with the rods. At the 
same time the glial and inner retinal cell types seem to be affected at a relatively early stage 
in retinal degenerative disease (Burstedt et al., 2003). 
2.3.2 Dark adaptometry and electrophysiology findings during 24 h prolonged dark-
adaptation conditions 
It has been shown that after illumination, the rhodopsin regeneration, 11-cis-retinal 
production, and dark adaptation are delayed by >10-fold in the visual cycle in RLBP1 
knockout mice (Saari et al., 2001). This could also be observed in humans, in six younger 
adults with BD, examined with a standardized Goldmann-Weekers adaptometer during an 
extremely prolonged dark adaptation of 24 hours (Burstedt et al., 2003). The extremely slow 
DA reaches steady state within 5 to 12 hours (Fig. 13); however, the final visual sensory 
thresholds do not return to normal levels after 24 hours of DA in most of the cases studied, 
probably affected by the disturbance in the normal function of CRALBP and lack of 
regeneration of 11-cis retinal in the RPE. An apparent plateau of recovery in the dark is 
observed, and duration for about 1 to 4 hours possibly represents a removal of bleached 
pigments, which has been suggested to occur in other retinal diseases affecting visual cycle 
function (Cideciyan et al., 1997). The 11-cis-retinal has been estimated to range from about 
3.5% to 8% of that in normal subjects (Lamb & Pugh, 2004), with an average level of about 
6% in the RPE in the BD phenotype. 
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Fig. 13. Results of extremely prolonged (24 h) dark-adaptometry examinations in single eyes 
in BD patients, n = 6 (age 12–47 years). The final thresholds after 24 h were measured in both 
the patched single eye and in the unpatched contralateral eye. The values of the unpatched 
contralateral eye are indicated as filled symbols (). The shaded area indicates normal range 
for corresponding age groups. (Figure published in Vision Research 2003:43(24):2559–2571). 
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Full-field ERGs after 24 hours of extremely prolonged DA were performed to evaluate the 
capacity of recovery of the whole retinal area and different cell types in BD disease. Six 
young cases (age 15–30 years) underwent full-field ERGs after 24 hours of DA in one eye 
and standard DA in the fellow eye. The results could be compared with the effect of the 
ERG after 10 hours’ prolonged DA from a previous study (Burstedt et al., 2003, 2008). 
Enhanced rod-isolated b-wave after extremely prolonged DA (24 h) shows a sufficient 
number of rods able to function, generating responses of normal amplitudes even in young 
BD patients, although still with prolonged peak times (Fig. 14). Since the b-wave of the ERG 
is a glial response reflecting a depolarization of the Müller cells (Miller & Dowling, 1970), 
these findings may be correlated to an affected CRALBP function in the Müller cells of the 
retina or possibly a reversible effect on the second-order ON-bipolar cell function, as a 
consequence of a change in photoreceptor function. 
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Fig. 14. Full-field electroretinograms of one eye, recorded after prolonged DA (10 h) and 
after extremely prolonged DA (24 h) in two BD patients (both 21 years old). A ‘second’, 
comparatively slowly rising positivity was observed in the mixed rod-cone response 
(arrows). For comparison, recordings of a normal subject are shown. (Figure published in 
Doc Ophthalmol. 2008;116(3):193–205). 
The mixed rod-cone b-wave amplitude created by depolarization of the Müller and ON-
bipolar cells in the inner retina is increased but still subnormal in the majority of patients. 
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After extended (24 h) DA, the mixed rod-cone a-wave response increases in amplitude to 
normal values in 4/5 cases with normal or somewhat delayed peak times. As the mixed a-
wave shows normalized responses in the majority of the young BD cases examined, and the 
leading edge of the a-wave mainly represents a light-evoked hyperpolarization of the 
photoreceptors (Brown, 1968; Jamison et al., 2001; Robson et al., 2003; Tomita, 1965), these 
data suggest an additional, extremely slow regeneration of photopigments occurring even 
after 10 h DA. No obvious recovery of the cone b-wave is noted after the extremely 
prolonged DA (24 h); therefore, a relatively early damage to the cone system in BD patients 
cannot be excluded. Even though regeneration of opsin photopigments has been 
demonstrated in cone-dominant retinas, suggesting an interaction between Müller cells and 
cones in the recycling of visual chromophore (Mata et al., 2002), these electrophysiological 
results cannot confirm these findings. 
In three younger BD patients a late evolvement in the mixed rod-cone response is observed 
(Fig. 14, arrows). The amplitudes are within the normal range of a mixed rod-cone b-wave, 
but the peak is extremely delayed (115 ms) compared to normal. This can be related to an 
enhanced scotopic activity associated with the slow and disturbed regeneration of 
photopigments. However, the exact origin of this late positive potential observed in BD 
patients is not known. 
In summary, the continuous but slow regeneration of rod photopigments in RLBP1 mutants 
presents an additional capacity for recovery of rod function and gain in activity in the inner 
retinal layers with extremely prolonged dark adaptation, possibly as a consequence of a 
change in photoreceptor function (Burstedt et al., 2003, 2008). 
2.4 Outcome of visual function 
Visual loss is an early sign of the BD disease, and individuals of working age may 
experience important socioeconomic consequences and interference with education as a 
result of their visual impairment. To provide insight into the perceived visual function of 
retinitis pigmentosa of Bothnia type, measurements of visual function were associated with 
the patients’ self-assessment of their total self-reported visual function and health-related 
quality of life, measured with a questionnaire in 49 BD cases (Burstedt et al., 2010). 
Significant correlation was found between objective visual functions studied, and the 
subjective visual function. Almost 70% of the variability of the composite score could be 
explained by WVA and age alone. BD patients’ responses to a majority of the questionnaire 
subscales significantly correlated with several of the clinical vision measures, especially 
those depending on central vision. Notably, the progressive declines in visual field area did 
not seem to affect significantly the self-perceived quality of life in patients with this 
phenotype. This finding might be an indication of ability to adapt to this type of gradual 
progressive visual field area loss, probably due to use of paracentral preserved areas. The 
expression of the disease has a significant impact on multiple domains of daily living, but 
there are no signs of worsening depression related to the increasing visual impairment. 
2.5 Tinted contact lenses in BD 
Could visual function be improved in BD? With the knowledge of an extremely prolonged 
dark adaptation (5–12 h) and even further gain of the ERG responses up to more than 12 h in 
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this phenotype, outcome of wearing of tinted contact lenses during daylight was tested 
(Jonsson et al., 2007). 
Twelve patients with BD were fitted with soft contact lenses tinted dark brown. Outcome of 
visual parameters, and visual-function questionnaire, were tested before the contact lens 
fitting and after one month. Visual function was improved by dark-tinted contact lenses, 
and it was observed that the BD cases with the lowest visual acuity described the most 
obvious improvement of their visual function and preferred the darker tinted contact lenses; 
the majority of BD cases from this study have also chosen to continue wearing the brown-
tinted contact lenses for several years following the study, possibly indicating a continuous 
benefit in their daily life over time (authors’ comments). 
Absorbance 50%   70%     90%
 
Fig. 15. Contact lenses with clear and different grades of tint were evaluated in retinitis 
pigmentosa of Bothnia type. 
3. Conclusions 
The RP population of northern Sweden has given us a unique opportunity to evaluate and 
compare the phenotypical expression of different RLBP1 mutations over time. Despite 
genetic heterogeneity, the clinical expression of different RLBP1 mutations in northern 
Sweden presents a unique phenotype of the retinal disease, clearly directing the molecular 
diagnosis and search for RLBP1 mutations. It became possible to offer genetic testing among 
the families related to BD patients and also to the patients with a hereditary form of the 
recessive form of RP. In BD families we can offer risk assessment to future generations, 
providing genetic counselling based on molecular testing and clinical findings. There are 
several approaches to treatment of RP patients, although there are no established standards. 
Several drugs and nutritional supplements such as vitamin A palmitate, ascorbic acid, 
docosahexaenoic acid and others were evaluated with contradictory outcomes in different 
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studies. Vitamin A palmitate, the most-used nutritional supplement, is shown to slow the 
rate of retinal degeneration, but this type therapy is not without controversy (Shintani et al., 
2009). Gene therapy, which replaces or turns off the mutant disease-causing gene, represents 
another option for treatment. Several years of basic research of RPE65-Lebers congenital 
amaurosis, a retinal disease affecting the visual cycle, by several independent research 
groups, resulted in clinical trials of human gene therapies during recent years, 
demonstrating short-term evidence of visual gain (Jacobson & Cideciyan, 2010; Musarella & 
MacDonald, 2011). Therefore, we suggest that for treatment of BD patients, gene therapy is 
the most promising option among other concepts in the treatment of retinitis pigmentosa. 
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